Summary
In conclusion, uncomplicated type A intramural hematoma patients with type 2 diabetes mellitus (receiving the “wait-and-watch strategy” and tight glycemic control) may have a lower aorta-related mortality, rates of aorta-related adverse events and reinterventions during the follow-up period than patients without diabetes mellitus. Moreover, in patients without diabetes mellitus, it seems logical to recommend prophylactic replacement of an aortic wall that presents the intramural hemorrhage, since the rates of aorta-related adverse events and reinterventions during the follow-up period were found to be obviously higher than those in patients with diabetes mellitus.